Mervyn Turner - Net Worth and Insider Trading

Mervyn Turner Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mervyn Turner owns 3 companies in total, including Merck & Co Inc (MRK) , SAB Biotherapeutics Inc (SABS) , and Merck & Co Inc (MRKPRB.PFD) .

Click here to see the complete history of Mervyn Turner’s form 4 insider trades.

Insider Ownership Summary of Mervyn Turner

Ticker	Comapny	Transaction Date	Type of Owner
MRK	Merck & Co Inc	2009-11-03	Chief Strategy Officer
SABS	SAB Biotherapeutics Inc	2021-10-22	director
MRKPRB.PFD	Merck & Co Inc	2009-11-03	Chief Strategy Officer

Mervyn Turner Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mervyn Turner Ownership Network

Ownership Network List of Mervyn Turner

No Data

Ownership Network Relation of Mervyn Turner

Mervyn Turner Owned Company Details

What does Merck & Co Inc do?

Who are the key executives at Merck & Co Inc?

Mervyn Turner is the Chief Strategy Officer of Merck & Co Inc. Other key executives at Merck & Co Inc include EVP & CFO Caroline Litchfield , Evp & Global Svcs & CFO Robert M Davis , and President & Human Health Int?l Joseph Romanelli .

Merck & Co Inc (MRK) Insider Trades Summary

Over the past 18 months, Mervyn Turner made no insider transaction in Merck & Co Inc (MRK). Other recent insider transactions involving Merck & Co Inc (MRK) include a net sale of 715 shares made by Joseph Romanelli , a net sale of 62,150 shares made by Steven Mizell , and a net sale of 378,350 shares made by Robert M Davis .

In summary, during the past 3 months, insiders sold 0 shares of Merck & Co Inc (MRK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 879,110 shares of Merck & Co Inc (MRK) were sold and 409 shares were bought by its insiders, resulting in a net sale of 878,701 shares.

Merck & Co Inc (MRK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Merck & Co Inc Insider Transactions

No Available Data

What does SAB Biotherapeutics Inc do?

Who are the key executives at SAB Biotherapeutics Inc?

Mervyn Turner is the director of SAB Biotherapeutics Inc. Other key executives at SAB Biotherapeutics Inc include director & 10 percent owner & Chief Executive Officer Eddie Joe Sullivan , CHIEF FINANCIAL OFFICER Michael King , and director & Executive Chairman Samuel J Reich .

SAB Biotherapeutics Inc (SABS) Insider Trades Summary

Over the past 18 months, Mervyn Turner made no insider transaction in SAB Biotherapeutics Inc (SABS). Other recent insider transactions involving SAB Biotherapeutics Inc (SABS) include a net purchase of 11,000 shares made by Samuel J Reich , a net purchase of 5,000 shares made by Michael King , and a net purchase of 1,740 shares made by Eddie Joe Sullivan .

In summary, during the past 3 months, insiders sold 0 shares of SAB Biotherapeutics Inc (SABS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SAB Biotherapeutics Inc (SABS) were sold and 1,774 shares were bought by its insiders, resulting in a net purchase of 1,774 shares.

SAB Biotherapeutics Inc (SABS)'s detailed insider trading history can be found in Insider Trading Tracker table.

SAB Biotherapeutics Inc Insider Transactions

No Available Data

What does Merck & Co Inc do?

Who are the key executives at Merck & Co Inc?

Mervyn Turner is the Chief Strategy Officer of Merck & Co Inc. Other key executives at Merck & Co Inc include President & Human Health Int?l Joseph Romanelli , Chief Marketing Officer Chirfi Guindo , and SVP & U.S. Market Johannes Jacobus Oosthuizen .

Merck & Co Inc (MRKPRB.PFD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Merck & Co Inc (MRKPRB.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merck & Co Inc (MRKPRB.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Merck & Co Inc (MRKPRB.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Merck & Co Inc Insider Transactions

No Available Data

Mervyn Turner Mailing Address

Above is the net worth, insider trading, and ownership report for Mervyn Turner. You might contact Mervyn Turner via mailing address: Merck & Co Inc, One Merck Drive, Whitehouse Station Nj 08889.

Discussions on Mervyn Turner

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.